Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 150
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 151
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
LATEST NEWS UPDATES | Medicines for diabetes, infections to cost 40% less -Rupali Mukherjee & Sushmi Dey

Medicines for diabetes, infections to cost 40% less -Rupali Mukherjee & Sushmi Dey

Share this article Share this article
published Published on Jul 17, 2015   modified Modified on Jul 17, 2015
-The Times of India

MUMBAI/NEW DELHI: Medicines widely used to treat diabetes, infections, pain and digestive disorders will cost 5-40% less with immediate effect, with the drug price regulator issuing an order to fix the prices of 39-odd formulations.

The National Pharmaceutical Pricing Authority's (NPPA) order, issued on Wednesday, includes drug combinations such as ciprofloxacin hydrochloride, cefotaxime, paracetamol, domperidone and metformin + glimepiride and amoxycillin + potassium clavulanate.

These drugs and combinations are marketed by companies such as Abbott, GlaxoSmithKline, Lupin, Cadila Healthcare, IPCA and Sun Pharma, among others. According to analysts, these drugs have a market size of around Rs 1,054 crore (moving annual total value).

The NPPA order covers combinations of drugs under the National List of Essential Medicines (NLEM) and one non-NLEM drug under the Drug Price Control Order, 2013. While NPPA has fixed the ceiling prices of around 35-odd formulations, those of 3-4 other drugs have been revised, official sources in the department of pharmaceuticals, ministry of chemicals & fertilizers, told TOI.

"The move impacts multinational drugmakers like Abbott Laboratories and GSK and domestic firms. The overall impact for companies would be minimal as these drugs do not form a significant portion of the overall sales of the company," Angel Broking VP (research — pharma) Sarabjit Kour Nangra said.

The NPPA directive comes a day after the Supreme Court asked the Centre to re-examine its drug pricing policy for essential medicines, calling it "unreasonable and irrational".

The Times of India, 17 July, 2015, http://timesofindia.indiatimes.com/india/Medicines-for-diabetes-infections-to-cost-40-less/articleshow/48106382.cms


Related Articles

 

Write Comments

Your email address will not be published. Required fields are marked *

*

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close